Waverton Investment Management Ltd raised its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 159,382 shares of the company's stock after purchasing an additional 17,968 shares during the quarter. HCA Healthcare comprises about 1.1% of Waverton Investment Management Ltd's investment portfolio, making the stock its 27th biggest position. Waverton Investment Management Ltd owned 0.06% of HCA Healthcare worth $64,767,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently bought and sold shares of the company. MFA Wealth Advisors LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare in the second quarter worth about $28,000. Bangor Savings Bank lifted its holdings in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company's stock worth $27,000 after buying an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC raised its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock valued at $31,000 after acquiring an additional 71 shares in the last quarter. Finally, Capital Performance Advisors LLP bought a new position in shares of HCA Healthcare in the 3rd quarter worth about $41,000. Institutional investors and hedge funds own 62.73% of the company's stock.
HCA Healthcare Trading Down 2.1 %
NYSE:HCA traded down $7.64 during trading hours on Tuesday, hitting $350.35. The stock had a trading volume of 1,416,123 shares, compared to its average volume of 1,179,014. HCA Healthcare, Inc. has a one year low of $229.28 and a one year high of $417.14. The company has a market cap of $88.74 billion, a price-to-earnings ratio of 15.87, a P/E/G ratio of 1.36 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The business's 50 day moving average is $388.86 and its 200-day moving average is $356.86.
HCA Healthcare Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.75%. The ex-dividend date is Friday, December 13th. HCA Healthcare's dividend payout ratio is 11.85%.
Analysts Set New Price Targets
Several analysts recently issued reports on HCA shares. Wells Fargo & Company raised their price target on HCA Healthcare from $395.00 to $400.00 and gave the stock an "equal weight" rating in a report on Wednesday, November 6th. Morgan Stanley assumed coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 price target for the company. Cantor Fitzgerald reiterated an "overweight" rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Wolfe Research upgraded HCA Healthcare to a "strong-buy" rating in a research report on Thursday, August 29th. Finally, TD Cowen cut their price objective on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. Five analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $385.00.
View Our Latest Analysis on HCA Healthcare
Insider Buying and Selling
In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company's stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company's stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.70% of the company's stock.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
